The immune system is also involved in IBD extra-intestinal manifestations (EIMs) [131] and in the so-called “paradoxical” complications triggered by biological drugs, such as anti-TNF-α agents [132,133]. The gene discussed is TNF; the disease is inflammatory bowel disease.